Clinical Trial Update: Impact of the Mylife CamAPS FX System With the DEXCOM G6 Sensor on T1D Patients in France

View source ↗

Summary

A clinical trial update shows recruitment is ongoing in France to evaluate the CamAPS FX closed-loop insulin delivery system using the Dexcom G6 CGM in people w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• CamAPS FX
• Dexcom G6

Snippet

Sponsor: mylife Diabetes Care AG | Conditions: Diabetes Type 1 | Status: RECRUITING